Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial.

Name: Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial.
Author: Favrais, Geraldine

Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial. — المؤلف: Favrais, Geraldine — BMJ open 20200129

المؤلف: Favrais, Geraldine
النشر: BMJ open 20200129
الوصف: e022739 p.
الموضوعات: Anticonvulsants؛ Clinical Trials, Phase II as Topic؛ Dose-Response Relationship, Drug؛ France؛ Humans؛ Hypoxia-Ischemia, Brain؛ Infant, Newborn؛ Levetiracetam